Regutatory T-cells in type 1 diabetes

被引:10
作者
Juedes, AE [1 ]
von Herrath, MG [1 ]
机构
[1] La Jolla Inst Allergy & Immunol, Div Dev Immunol, San Diego, CA USA
关键词
autoimmunity; cytokines; regulation; therapy; T-cells;
D O I
10.1002/dmrr.508
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Type 1 diabetes is a T-cell-mediated autoimmune disease, resulting in destruction of the insulin-producing beta cells in the pancreas. Disease progression is thought to involve the action of T-cells particularly those understanding the producing Th1-type cytokines. Given the complexity in precise etiology of autoimmune diseases, the diversity of autoantigens, and the variability that exists between individual patients, it might be very difficult to eliminate autoaggressive T-cell responses without resorting to generalized means of immunosuppression. However, recent evidence shows that autoimmune processes are composed not only of autoaggressive T-cell responses but also of autoreactive regulatory components. Enhancing regulatory T-cell responses, therefore, has become an area of intense focus as a means of treating autoimmune diseases like type 1 diabetes. This review will concentrate on two different types of regulatory T-cells, the naturally occurring ('professional') CD4(+)CD25(+) T-cells and antigen-induced ('adaptive') CD4(+) Th2-like regulatory T-cells. Copyright (C) 2004 John Wiley Sons, Ltd.
引用
收藏
页码:446 / 451
页数:6
相关论文
共 50 条
  • [42] Antigen-specific induction of regulatory T cells for type 1 diabetes therapy
    Filippi, C
    Bresson, D
    von Herrath, M
    INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2005, 24 (5-6) : 341 - 360
  • [43] Lymphopenia is detrimental to therapeutic approaches to type 1 diabetes using regulatory T cells
    Ash, Shifra
    Yarkoni, Shai
    Askenasy, Nadir
    IMMUNOLOGIC RESEARCH, 2014, 58 (01) : 101 - 105
  • [44] Foxp3+ Regulatory T Cells in Mouse Models of Type 1 Diabetes
    Petzold, Cathleen
    Riewaldt, Julia
    Watts, Deepika
    Sparwasser, Tim
    Schallenberg, Sonja
    Kretschmer, Karsten
    JOURNAL OF DIABETES RESEARCH, 2013, 2013
  • [45] Harnessing memory adaptive regulatory T cells to control autoimmunity in type 1 diabetes
    Li, Cheng-Rui
    Baaten, Bas J. G.
    Bradley, Linda M.
    JOURNAL OF MOLECULAR CELL BIOLOGY, 2012, 4 (01) : 38 - 47
  • [46] Circulating CXCR5−PD-1hi peripheral T helper cells are associated with progression to type 1 diabetes
    Ilse Ekman
    Emmi-Leena Ihantola
    Tyyne Viisanen
    Deepak A. Rao
    Kirsti Näntö-Salonen
    Mikael Knip
    Riitta Veijola
    Jorma Toppari
    Jorma Ilonen
    Tuure Kinnunen
    Diabetologia, 2019, 62 : 1681 - 1688
  • [47] Cholecalciferol supplementation improves suppressive capacity of regulatory T-cells in young patients with new-onset type 1 diabetes mellitus - A randomized clinical trial
    Treiber, Genies
    Prietl, Barbara
    Froehlich-Reiterer, Elke
    Lechner, Evelyne
    Ribitsch, Anja
    Fritsch, Maria
    Rami-Merhar, Birgit
    Steigleder-Schweiger, Claudia
    Graninger, Winfried
    Borkenstein, Martin
    Pieber, Thomas R.
    CLINICAL IMMUNOLOGY, 2015, 161 (02) : 217 - 224
  • [48] Combination of double negative T cells and anti-thymocyte serum reverses type 1 diabetes in NOD mice
    Liu, Tianhui
    Cong, Min
    Sun, Guangyong
    Wang, Ping
    Tian, Yue
    Shi, Wen
    Li, Xinmin
    You, Hong
    Zhang, Dong
    JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14
  • [49] The role of ICAM-1 on T-cells in the pathogenesis of asthma
    Stanciu, LA
    Djukanovic, R
    EUROPEAN RESPIRATORY JOURNAL, 1998, 11 (04) : 949 - 957
  • [50] T-cells in human encephalitis
    Bien, CG
    Bauer, J
    NEUROMOLECULAR MEDICINE, 2005, 7 (03) : 243 - 253